US Broker Ratings

Syndax Pharmaceuticals, Inc. (SNDX) Stock Analysis: A 94.3% Upside Potential Amid Biotech Innovations

Individual investors eyeing the biotechnology sector may find Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) an intriguing prospect given its innovative cancer therapies and promising market performance indicators. Operating in the healthcare..

Delcath Systems, Inc. (DCTH) Investor Outlook: A 124% Potential Upside in the Expanding Oncology Market

Delcath Systems, Inc. (NASDAQ: DCTH) has recently captured the attention of investors with its notable potential upside of 124.62%, according to analyst ratings. As an interventional oncology company, Delcath is..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: Exploring a 148% Potential Upside

Enliven Therapeutics, Inc. (NASDAQ: ELVN), a clinical-stage biopharmaceutical company, is gaining attention in the biotechnology sector for its promising pipeline of cancer therapies. Headquartered in Boulder, Colorado, Enliven Therapeutics is..

Gyre Therapeutics, Inc. (GYRE) Stock Analysis: Uncovering a 144.90% Potential Upside in the Biotech Arena

Gyre Therapeutics, Inc. (NASDAQ: GYRE), a promising player in the biotechnology sector, has caught the attention of individual investors with its substantial market cap of $708.05 million and a remarkable..

iRadimed Corporation (IRMD) Stock Analysis: A Healthcare Leader with a Robust 15.7% Revenue Growth

iRadimed Corporation (NASDAQ: IRMD) operates at the intersection of healthcare and technology, focusing on innovative MRI-compatible medical devices. With its headquarters in Winter Springs, Florida, the company has carved out..

Avadel Pharmaceuticals plc (AVDL) Stock Report: Understanding the 54.9% Revenue Growth Amidst Market Challenges

Avadel Pharmaceuticals plc (NASDAQ: AVDL), an Ireland-based specialty drug manufacturer, has captured investor attention with its robust revenue growth of 54.9% over the past year. As a player in the..

STAAR Surgical Company (STAA) Stock Analysis: Navigating Growth with a 10.58% Upside Potential

STAAR Surgical Company (NASDAQ: STAA), a prominent player in the healthcare sector specializing in medical instruments and supplies, is making waves with its innovative solutions in the world of ophthalmology...

Beta Bionics, Inc. (BBNX) Stock Analysis: Growth Potential and Analyst Consensus Point to an 11.15% Upside

Beta Bionics, Inc. (NASDAQ: BBNX), a promising player in the healthcare sector, particularly within the medical devices industry, is making waves with its innovative solutions aimed at improving the lives..

Weave Communications, Inc. (WEAV) Stock Analysis: Potential 47% Upside in the Health Information Services Sector

Weave Communications, Inc. (NYSE: WEAV) presents a compelling opportunity for investors eyeing the health information services industry. As a key player in providing customer experience and payments software for small..

Simulations Plus, Inc. (SLP) Stock Analysis: Exploring a 20% Potential Upside in Health Information Services

Simulations Plus, Inc. (NASDAQ: SLP) stands as a compelling player in the healthcare sector, specifically within the health information services industry. Known for its innovative use of artificial intelligence and..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Exploring a Potential 19.98% Upside Amidst Healthcare Sector Growth

Fulgent Genetics, Inc. (NASDAQ: FLGT) is a burgeoning player in the healthcare sector, specifically within the diagnostics and research industry. Known for its innovative approach to clinical diagnostics and therapeutic..

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: Exploring a 57.76% Potential Upside in the Biotech Sector

Nurix Therapeutics, Inc. (NASDAQ: NRIX), a clinical-stage biopharmaceutical company, is making waves in the biotechnology industry with its innovative approach to small molecule and antibody therapies. With a current market..

Ardelyx, Inc. (ARDX) Stock Analysis: A Biotech Gem with a 105.99% Potential Upside

Ardelyx, Inc. (NASDAQ: ARDX) has caught the attention of investors with its notable potential upside of 105.99%, according to analyst projections. As a player in the biotechnology sector, Ardelyx is..

AMN Healthcare Services Inc (AMN) Stock Analysis: Exploring a Potential 26% Upside

For investors looking to delve deeper into the healthcare sector, AMN Healthcare Services Inc (NYSE: AMN) presents a compelling case. With a market capitalization of $630.75 million, AMN operates within..

Nuvation Bio Inc. (NUVB) Stock Analysis: 1704% Revenue Growth Sparks Investor Interest in Biotech Innovator

Nuvation Bio Inc. (NASDAQ: NUVB), a clinical-stage biopharmaceutical company with a focus on oncology, is turning heads in the biotech investment community. With an impressive revenue growth of 1,704.70%, Nuvation..

Nutex Health Inc. (NUTX): Investor Outlook on a Healthcare Powerhouse with 49.84% Upside Potential

Nutex Health Inc. (NUTX), a prominent player in the healthcare sector, is catching the attention of investors with its impressive performance metrics and substantial growth potential. Headquartered in Houston, Texas,..

HealthStream, Inc. (HSTM) Stock Analysis: Exploring a 39.98% Potential Upside in the Healthcare SaaS Market

HealthStream, Inc. (NASDAQ: HSTM) stands out as a compelling investment opportunity within the Health Information Services industry, driven by its robust Software-as-a-Service (SaaS) offerings tailored for healthcare organizations. Headquartered in..

CorMedix Inc. (CRMD) Stock Analysis: Potential 59.40% Upside as Biotech Innovates with DefenCath

CorMedix Inc. (NASDAQ: CRMD) is capturing investor attention in the biotech sector with its groundbreaking therapeutic developments and impressive growth metrics. Incorporated in 2006 and headquartered in Berkeley Heights, New..

Similarweb Ltd. (SMWB) Stock Analysis: A Promising Upside of Over 78%

In the ever-evolving landscape of digital analytics, Similarweb Ltd. (NASDAQ: SMWB) stands out as a noteworthy player, providing critical insights for businesses across the globe. Despite recent fluctuations in its..

Paycom Software, Inc. (PAYC) Investor Outlook: Unpacking a 25% Potential Upside and Strong Analyst Support

Paycom Software, Inc. (NYSE: PAYC), a leading provider of cloud-based human capital management solutions, has captured the attention of investors with its robust suite of software offerings and a notable..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds